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692Objective: Acute kidney injury is a well-known complication with high morbidity and mortality after cardiopul-
monary bypass. Cardiopulmonary bypass–associated acute kidney injury is still poorly understood.
Methods: Thirty-six patients undergoing elective cardiopulmonary bypass were enrolled. Spot urine samples be-
fore and after cardiopulmonary bypass were collected. Acute kidney injury was defined according to the RIFLE
classification. To identify differentially regulated proteins after cardiopulmonary bypass, we first analyzed the
urinary proteome before and after cardiopulmonary bypass. To identify differentially regulated proteins in acute
kidney injury, we next compared the urinary proteome obtained on the first postoperative day between patients
with and without acute kidney injury. Difference fluorescence gel electrophoresis was used to compare protein
profiles and mass spectrometry to identify individual proteins.
Results: After cardiopulmonary bypass, inflammation-associated (zinc-alpha-2-glycoprotein, leucine-rich
alpha-2-glycoprotein, mannan-binding lectin serine protease 2, basement membrane-specific heparan sulfate pro-
teoglycan, and immunoglobulin kappa) or tubular dysfunction-associated (retinol-binding protein, adrenomedul-
lin-binding protein, and uromodulin) proteins were differentially regulated. Acute kidney injury developed in 6
of 36 patients. A modified urinary albumin was increased, and zinc-alpha-2-glycoprotein and a fragment of adreno-
medullin-binding protein were decreased in patients with acute kidney injury. Decreased excretion of zinc-alpha-
2-glycoprotein in patients with acute kidney injury was confirmed by Western blot and enzyme-linked immunosor-
bent assay in an independent cohort of 22 patients with and 46 patients without acute kidney injury.
Conclusion: Cardiopulmonary bypass leads to increased urinary excretion of inflammatory proteins and markers
of tubular injury. Zinc-alpha-2-glycoprotein is a potentially useful predictive marker for acute kidney injury after
cardiopulmonary bypass surgery. (J Thorac Cardiovasc Surg 2010;139:692-700)Acute kidney injury (AKI) is a well-known serious compli-
cation after cardiac surgery. The incidence of AKI is 5% to
30%, depending on its definition.1 Mortality of patients with
AKI requiring renal replacement therapy is as high as 80%.1
The precise mechanisms of AKI after cardiopulmonary by-
pass (CPB) are still debated. Possible contributors leading
to acute tubular damage are ischemia–reperfusion injury,
atheroembolism, hypothermia, and nephrotoxic agents.
Several up-regulated proteins in urine have been identified
after CPB, correlating with tubular damage,2 inflamma-
tion,3 or oxidative stress.4 Presently, AKI is typically diag-
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The Journal of Thoracic and Cardiovascular Surga parameter without predictive value for acute changes in
kidney function. Thus, prognostic biomarkers for AKI
are needed.
The identification of patterns of urinary proteins for non-
invasive diagnosis of renal diseases has a long history,5 with
a recent revival because of advances in clinical proteomics
allowing the discovery of novel biomarkers with potential
clinical utility.2,6 Two-dimensional (2D) polyacrylamide
gel electrophoresis, a promising tool in proteome research,
allows the separation of complex mixtures of intact proteins
at high resolution, differentiation of a variety of post-trans-
lationally modified isoforms, and determination of differen-
tially expressed proteins.7,8 Unlu and colleagues9 first
described 2D fluorescence difference gel electrophoresis
(DIGE), enabling the separation of more than 1 sample in
a single 2D gel. The comparison of 2 protein samples on
the same gel is a sensitive strategy for detecting and quanti-
fying differences in the proteome before and after an inter-
vention such as CPB, as proposed in the present
investigation. The use of an internal standard for normaliza-
tion minimizes experimental variations, thus increasing con-
fidence in matching and quantifying different spots from the
same or different patients.10 The aim of the current study was
to detect differential regulation in the urinary proteome be-
fore and after CPB using DIGE to analyze mechanismsery c March 2010
Abbreviations and Acronyms
2D ¼ 2-dimensional
AKI ¼ acute kidney injury
AMBP ¼ adrenomedullin-binding
protein
AUC ¼ area under the curve
CPB ¼ cardiopulmonary bypass
DIGE ¼ difference gel electrophoresis
eGFR ¼ estimated glomerular filtration
rate
ELISA ¼ enzyme-linked
immunosorbent assay
GFR ¼ glomerular filtration rate
HSPG ¼ heparan sulfate proteoglycan
MALDI-MS ¼ matrix-assisted laser
desorption ionization time-of-
flight mass spectrometry
MALDI-MS/MS ¼ matrix-assisted laser
desorption ionization time-of-
flight mass spectrometry/mass
spectrometry
NGAL ¼ neutrophil gelatinase-
associated lipocalin
RBP ¼ retinol-binding protein
SELDI-TOF-MS ¼ surface-enhanced laser
desorption/ionization time-of-
flight mass spectrometry
SIRS ¼ systemic inflammatory
response syndrome
ZAG ¼ zinc-alpha-2-glycoprotein
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Minvolved in AKI after CPB. Because early biomarkers for
AKI are lacking, we analyzed the postoperative urinary pro-
teome in patients with and without AKI.
MATERIALS AND METHODS
Subjects and Sample Collection
Written informed consent was obtained from all patients, according to
local ethics committee approval. Patients aged more than 18 years who
underwent elective CPB between January 2006 and May 2006 were en-
rolled prospectively. Exclusion criteria included proteinuria greater than
1 g/24 hours, microhematuria (5 erythrocytes per high power field), es-
timated glomerular filtration rate (eGFR) less than 40 mL/min, use of ra-
dio contrast media or nonsteroidal anti-inflammatory drugs in the previous
10 days, and need for urgent surgery. In case of the DIGE analysis group
(A), first morning urine samples were collected from 36 patients on the
day of operation and the first postoperative day. Urine was immediately
centrifuged at 1000 rpm for 5 minutes. The supernatant was filtered
through a 0.22 mm filter unit (Millipore, Bedford, Mass) and stored at
–70 C until further analysis according to the suggestion of Thongboon-
kerd.11 For a second group (111 patients), which was not analyzed by
DIGE (validation group B), urine was collected only on the first post-
operative day.The Journal of Thoracic and CaSurgical Procedure and Serial Analysis of Renal
Function
Surgery was performed according to standard local practice, and CPB
was conducted in moderate hypothermia (32 C–34 C). All patients re-
ceived antifibrinolytic drugs to decrease postoperative blood loss (aprotinin
in all 36 patients in group A; tranexamic acid [Cyklokapron; Pfizer US Phar-
maceuticals, New York, NY] in all 111 patients in group B). Routine serum
creatinine concentrations were measured daily for the first 3 days and after-
ward according to standard local practice until discharge (Creatinine Plus;
Roche Diagnostics, West Sussex, UK). Urine dipstick measurements (Ark-
ray Aution, ARKRAY Inc, Kyoto, Japan) were performed in all samples.
Protein Preparation for Difference Gel
Electrophoresis
Samples thawed on ice were precipitated according to the method of
Bensadoun and Weinstein12 with slight modifications. Briefly, 200 mL of
2% sodium deoxycholate (Sigma-Aldrich, St Louis, Mo) were added to
20 mL of urine. After incubation on ice for 30 minutes, trichloroacetic
acid (Fluka AG, St Louis, Mo) was added to a final concentration of
10%. Samples were then incubated overnight at 4 C and centrifuged at
14,000 rcf for 1 hour. The supernatant was discarded and the pellet was
washed twice with 90% acetone, followed by resuspension of the pellet
in DIGE buffer according to the manufacturer’s instructions (GE Health-
care, Buckinghamshire, UK). Protein concentrations were measured accord-
ing to the Bradford method.13
Study Design and 2-Dimensional Electrophoresis
AKI was defined according to the RIFLE classification.14 Three degrees
of kidney dysfunction were assigned as Risk (increase of serum creatinine>
50% or GFR decrease>25% or oliguria), Injury (increase of serum creat-
inine>100% or GFR decrease>50% or oliguria), and Failure (increase in
serum creatinine>200% or GFR decrease>75% or serum creatinine>4
mg/dL or oliguria). Because of incomplete data of urinary output quantifi-
cation, we did not include the criteria of oliguria for classification. eGFR
was calculated with the simplified Modification of Diet in Renal Disease
formula using serum creatinine, age, race, and gender. The study design
is given in Figure 1. For each of the 6 patients in whom AKI developed,
1 patient from the other 30 patients who did not develop AKI was selected
as a match. Gender and age were used as matching criteria.
To compare preoperative with postoperative urinary proteome, 12 DIGE
gels were run simultaneously from 6 patients undergoing CPB with AKI
and 6 patients undergoing CPB without AKI. Urinary proteins (50 mg) were
labeled with CyDye DIGE Fluor minimal dye. Cy3Dye was used for labeling
the protein samples before CPB and Cy5Dye after CPB. To guarantee uniform
distribution, the labeling was inverted in half of the patients. Cy2Dye labeling
was used for the internal standardization. For this purpose, 50 mg of a mixture
of all samples investigated on a given run were analyzed. After labeling pro-
teins of each patient (sample before and after CPB plus internal standard), sam-
ples were pooled and loaded onto an IPG dry strip pH 3-11 (GE Healthcare).
To compare the postoperative urinary proteome between patients with
and without AKI, urinary proteins were labeled with Cy3Dye in patients
with AKI and Cy5Dye in patients without AKI and vice versa. Six gels
were run, each including a sample of a patient with AKI, a patient without
AKI, and the internal standard, and further analyzed as described below.
After isoelectric focusing (total 73 kVh), the IPG strip was equilibrated
in dithiothreitol buffer and iodoacetamide buffer for 15 minutes sequen-
tially. The second dimension was conducted with a 13% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis for 6 hours.
Gel Image Analysis
Labeled proteins were visualized using a Typhoon 9400 imager (GE
Healthcare). Spot matching, quantification, and statistical analyses were
performed using Proteomweaver software (Definiens AG, Munich,rdiovascular Surgery c Volume 139, Number 3 693
FIGURE 1. Patient selection and study design. Forty-three patients were excluded in group B for the following reasons: contrast media in the previous 10
days (N ¼ 19), emergency procedure (N ¼ 13), eGFR<40 mL/min (N ¼ 10), and proteinuria>1 g/d (N ¼ 1). AKI, Acute kidney injury; CPB, cardiopul-
monary bypass; DIGE, difference fluorescence gel electrophoresis; ELISA, enzyme-linked immunosorbent assay.
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MGermany) as previously described.8 Protein spots were considered to be sig-
nificantly differentially regulated when the P value was less than .05 and the
regulation factor was greater than 2.
Protein Identification
For identification of differential regulated proteins, individual spots were
cut from the gel and trypsin digested. Extracted peptides were analyzed by
matrix-assisted laser desorption ionization time-of-flight mass spectrometry
(MALDI-MS) and matrix-assisted laser desorption ionization time-of-flight
mass spectrometry/mass spectrometry (MALDI-MS/MS).8
Validation
Western blot technology was used to analyze reproducibility of the re-
sults derived from DIGE in the same sample set. ZAG was chosen for val-
idation because it was the only full-length protein identified differentially
regulated in patients with AKI. Therefore, 5 mg of urine protein were loaded
onto a 12% sodium dodecyl sulfate-polyacrylamide gel and separated by
electrophoresis. Proteins were electroblotted onto polyvinylidene fluoride
membrane (GE Healthcare). Rabbit antibody against ZAG (1:5000, Santa
Cruz Biotechnology, Santa Cruz, Calif) was used. The intensity of Western
blot bands were quantified with ImageJ.
Because the finding by DIGE was reproducible by Western blot, an inde-
pendent group of 68 patients were analyzed for validation (group B). In these
patients, urinary ZAG was determined by enzyme-linked immunosorbent as-
say (ELISA) (BioVendor, Brno, Czech Republic) according to the manufac-
turer’s instruction. For validation, investigators were blinded to the patients’
outcome. ZAG excretion was normalized with the total protein excretion.
Statistical Analysis
Values are given as mean  standard deviation, or median and range.
Nonparametic tests (Mann–Whitney) were performed. Chi-square analysis
and Fisher exact tests were considered for discrete data. Correlation analysis
was performed using Spearman’s coefficient of rank correlation. Bonferroni
correction was applied to the clinical data to correct for multiple testing. Re-
ceiver operating characteristics were generated, and the area under the curve
(AUC) was calculated with GraphPad Prism v.5.01.694 The Journal of Thoracic and Cardiovascular SurgRESULTS
Clinical Data
Clinical data of groups A and B are summarized in Table 1.
Of the 111 patients considered for validation (Figure 1), 43
were excluded for the following reasons: contrast media in
the previous 10 days (N ¼ 19), emergency procedure (N ¼
13), eGFR less than 40 mL/min (N ¼ 10), and proteinuria
more than 1 g/d (N ¼ 1), resulting in 68 patients eligible
for validation. AKI, according to the RIFLE classification,
occurred in 17% in group A and in 34% in group B. In group
A, 3 patients had risk and 3 patients had injury.14 In group B,
18 patients had risk, 3 patients had injury, and 2 patients had
failure. One patient in group B had to be dialyzed, and 1 pa-
tient with AKI died. The mean time to reach maximal creat-
inine was 4.33  1.4 days in group A and 3.4  1.1 days in
group B. Patients with AKI were more frequently female,
more frequently developed atrial fibrillation, and had longer
hospitalizations and lower postoperative renal function
(Table 1, group B).Protein Pattern Before and After Cardiopulmonary
Bypass
Urine samples of the 6 patients with AKI and the 6
matched patients without AKI were analyzed before and af-
ter CPB using DIGE. Each gel contained the urinary pro-
teome before and after CPB, as well as the internal
standard (Figure 2, A–C). All differentially regulated pro-
teins that could be visualized by Coomassie staining were
picked. Twenty-five differentially regulated spots could be
identified by MALDI-MS and MALDI-MS/MS; they corre-
sponded to 10 proteins (Figure 2, D; Table 2).ery c March 2010
TABLE 1. Characteristics of study population
Group A Group B
AKI No AKI P AKI No AKI P
No. of patients 6 6 23 45
Baseline
Age, y (mean  SD) 72  7 68  8 NS 70  11 63  11 NS
Female, n (%) 2 (33) 2 (33) NS 15 (65) 7 (16) <.001
Hypertension, n (%) 4 (67) 5 (83) NS 16 (70) 23 (51) NS
Diabetes, n (%) 0 (0) 2 (33) NS 4 (17) 10 (22) NS
Creatinine mmol/L (mean  SD) 84  13 78  11 NS 79  17 78  11 NS
eGFR mL/min (mean  SD) 71  10 80  12 NS 74  20 86  13 NS
eGFR<60 mL/min, n (%) 1 (17) 1 (17) NS 5 (22) 0 (0) NS
Outcome
Surgery
CABG, n (%) 5 (83) 5 (83) NS 7 (30) 29 (64) NS
Valve, n (%) 0 (0) 0 (0) NS 12 (52) 9 (20) NS
Combined, n (%) 1 (17) 1 (17) NS 4 (17) 7 (16) NS
Time on ECC (min) (mean  SD) 80  26 99  36 NS 91  40 80  32 NS
ACT (min) (mean  SD) 59  25 56  16 NS 63  27 55  27 NS
Maximum serum
creatinine mmol/L (mean  SD)
153  38 84  12 NS 138  78 83  13 <.001
Minimal eGFR mL/min (mean  SD) 37  9 73  11 <.003 46  20 80  14 <.001
Decrease in eGFR,% (mean  SD) 47  12 9  7 <.003 39  16 4  12 <.001
Red blood
cell units, n (mean  SD)
2.7  2.3 1.0  0.9 NS 4.2  5.0 2.0  1.8 NS
Infection, n (%) 0 (0) 0 (0) NS 2 (9) 2 (4) NS
Atrial fibrillation, n (%) 3 (50) 3 (50) NS 14 (61) 8 (18) <.001
Days of hospitalization, median (range) 11 (10–14) 12 (7–12) NS 13 (9–48) 10 (6–38) <.001
AKI, Acute kidney injury; SD, standard deviation; eGFR, estimated glomerular filtration rate; CABG, coronary artery bypass graft; ECC, extracorporeal circulation; ACT, aortic
clamp time; NS, not significant.
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MUp-regulated proteins were zinc-alpha-2-glycoprotein
(ZAG), adrenomedullin-binding protein (AMBP), immuno-
globulin kappa (immunoglobulin kappa variable 1-5 pro-
tein), leucine-rich alpha-2-glycoprotein, gelsolin, carbonic
anhydrase-1, plasma retinol-binding protein (RBP), man-
nan-binding lectin serine protease 2, and basement mem-
brane-specific heparan sulfate proteoglycan (HSPG). The 2
down-regulated spots were identified as uromodulin.
Whereas all of the spots represented the entire protein,
HSPG only appeared as its fragment, named ‘‘endorepel-
lin.’’Differently Regulated Proteins in Patients With
Acute Kidney Injury
To identify proteins regulated differently in patients with
AKI after CPB, we analyzed the urinary proteome of 6 pa-
tients with AKI and 6 patients without AKI. Four differen-
tially regulated proteins in patients with AKI could be
identified as ZAG, AMBP, and serum albumin. AMBP ap-
peared as its fragment and was together with ZAG down-
regulated in AKI urine. The only up-regulated protein spot
was a modified albumin (Figure 2, H; Table 3). We decided
to further validate the nonmodified and nonfragmented pro-
tein ZAG by Western blot and ELISA.The Journal of Thoracic and CaValidation of Zinc-Alpha-2-Glycoprotein
There was a significant correlation of the results from
DIGE analysis and Western blot for urinary ZAG in the 12
patients analyzed (Figure 3, B). For validation of the differ-
ences observed by DIGE in these patients, a cohort of 68 pa-
tients (22 with AKI and 46 without AKI) were analyzed.
Median ZAG excretion was lower in subjects with AKI
(0.029; range, 0.009–0.106) than those without AKI
(0.056; range, 0.008–0.32; P< .02; Figure 3, C).
Furthermore, there was a significant association of urinary
ZAG with minimal postoperative eGFR compared with
baseline (r¼ 0.32, P<.01; Figure 3, D). Receiver operating
characteristics of the 68 patients revealed an AUC of 0.68 for
ZAG (0.55–0.81, P<.02). In the subgroup analysis of the 5
patients with severe AKI (3 with injury and 2 with failure)
compared with all 45 patients without AKI, the AUC was
0.80 for ZAG (0.61–0.98, P< .05).DISCUSSION
The present investigation analyzed the urinary proteome
in a highly selected and well-defined population of subjects
before and after CPB and compared the first postoperative
urinary proteome between patients in whom AKI later didrdiovascular Surgery c Volume 139, Number 3 695
FIGURE 2. Representative example of 2D-DIGE gels. A, Cy3-labeled proteins (50 mg) of urine before CPB. B, Cy5-labeled proteins (50 mg) of the same
patient after CPB. C, color overlay of scanned gel images of urine proteins before CPB labeled with Cy3 and after CPB labeled with Cy5. D, 2D map of Cy2-
labeled proteins showing the location of significantly regulated and identified protein spots with a numbering system used as in Table 2. E, Comparison of spot
18 intensity among all patients in DIGE experiment (position 1-12); green bars represent the intensity before CPB and blue bars represent the intensity after
CPB. F, G, Three-dimensional image of gelsolin protein spot (spot no. 18 or boxed area in D) before and after CPB. H, Differentially regulated protein spots in
postoperative urine samples from patients with or without AKI. Highlighted spots in the 2D map represent significantly regulated and identified protein spots;
the numbering system is that used in Table 3.
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Mor did not develop. We identified 10 differentially regulated
proteins excreted in urine after CPB and obtained evidence
that ZAG might be a useful predictive markers for AKI after
CPB surgery.696 The Journal of Thoracic and Cardiovascular SurgThe changes in the rate of urinary excretion of a defined
protein as shown in the present investigation can be due to
an increased production rate or an abnormal renal handling.
The present study was unable to distinguish between theseery c March 2010
TABLE 2. Changes and identifications of urinary proteins after extracorporeal circulation
Accession Fold change in Theoretic MASCOT
No. of
matching Sequence
No. of
matching
Spot no.* Protein no. intensity Mr/pIy scorez peptides coverage (%) MS/MS
1 Zinc-alpha-2-glycoprotein P25311 (þ) 3.14 33.8/5.6 94 6 25.8 2
2 Zinc-alpha-2-glycoprotein P25311 (þ) 3.31 33.8/5.6 177 12 38.3 2
3 Zinc-alpha-2-glycoprotein P25311 (þ) 3.80 33.8/5.6 184 13 38.6 2
4 Zinc-alpha-2-glycoprotein P25311 (þ) 2.88 33.8/5.6 127 8 21.0 2
5 Zinc-alpha-2-glycoprotein P25311 (þ) 2.08 33.8/5.6 113 9 30.8 2
6 Adrenomedullin-binding protein P02760 (þ) 2.92 39.0/5.8 59 6 20.2 1
7 Adrenomedullin-binding protein P02760 (þ) 3.51 39.0/5.8 116 3 9.7 3
8 Adrenomedullin-binding protein P02760 (þ) 3.37 39.0/5.8 151 7 20.2 2
9 Adrenomedullin-binding protein P02760 (þ) 3.51 39.0/5.8 218 8 15.6 3
10 Adrenomedullin-binding protein P02760 (þ) 3.92 39.0/5.8 193 7 23.6 3
11 IGKV 1-5 protein Q6GMW0 (þ) 2.00 25.7/5.8 111 3 33.0 2
12 IGKV 1-5 protein Q6GMW0 (þ) 2.22 25.7/5.8 56 3 14.0 1
13 IGKV 1-5 protein Q6PIH6 (þ) 2.30 26.2/6.3 91 4 18.3 1
14 IGKV 1-5 protein Q6GMW0 (þ) 2.67 25.7/5.8 137 3 14.0 3
15 IGKV 1-5 protein Q6GMW0 (þ) 2.99 25.7/5.8 68 4 21.7 2
16 Leucine-rich alpha-2-glycoprotein P02750 (þ) 3.35 38.2/5.7 64 3 8.0 3
17 Gelsolin Q5T0H7 (þ) 2.29 20.8/4.7 59 3 10.1 1
18 Gelsolin Q5T0H7 (þ) 2.83 20.8/4.7 120 6 34.6 2
19 Carbonic anhydrase 1 P00915 (þ) 3.60 28.7/6.6 109 4 16.1 2
20 Plasma retinol-binding protein P02753 (þ) 5.10 23.0/5.3 88 5 18.9 2
21 Plasma retinol-binding protein P02753 (þ) 5.57 23.0/5.3 248 12 51.7 2
22 Mannan-binding lectin
serine protease 2
O00187 (þ) 2.73 75.6/5.4 122 4 5.7 4
23 Basement membrane-specific HSPG P98160 (þ) 2.31 468.5/6.0 659 18 5.8 9
24 Uromodulin P07911 (–) 2.44 69.7/5.0 118 11 18.1 1
25 Uromodulin P07911 (–) 3.70 67.7/5.0 117 11 18.1 1
Mr/pI, Molecular mass/isoelectric point; MS/MS, mass spectrometry/mass spectrometry; HSPG, heparan sulfate proteoglycan; IGKV, immunoglobulin kappa variable. *Spot num-
ber according to Figure 2, D. yTheoretic molecular mass and isoelectric point were calculated with the Compute pI/MW Tool from ExPASy (http://expasy.org/tools/pi_tool.html).
zMASCOT score>61 were significant (P< .05) identifications.
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physiology of these proteins and the disease state induced
by CPB, some reasonable speculations may be appropriate.
First, RBP and AMBP are well-known markers of proxi-
mal tubular dysfunction of various cause,15,16 including tu-
bulopathy after cardiac surgery.3 These proteins are freely
filtered by the glomerulus. A relevant mechanism of proxi-
mal tubular uptake of filtered proteins, including RBP,
AMBP, immunoglobulin light chains, and albumin, is recep-
tor-mediated endocytosis by megalin and cubilin.17 In rats
with acute tubular injury induced by aristolochic acid andTABLE 3. Comparison of urinary proteins between patients with and w
proteins in patients with acute kidney injury
Accession Fold change in Th
Spot No.* Protein No. intensity M
1 Serum albumin P02768 (þ) 4.46 66
2 Zinc-alpha-2-glycoprotein P25311 (–) 2.00 32
3 Zinc-alpha-2-glycoprotein P25311 (–) 2.04 32
4 Adrenomedullin-binding protein P02760 (–) 2.56 39
Mr/pI, Molecular mass/isoelectric point; MS/MS, mass spectrometry/mass spectrometry. *S
were calculated with the Compute pI/MW Tool from ExPASy (http://expasy.org/tools/pi_t
The Journal of Thoracic and Catotal body irradiation, proteinuria appeared on day 1 after
the toxic event, followed by an impaired expression of meg-
alin and cubilin on day 2.18 The up-regulation of RBP,
AMBP, immunoglobulin kappa variable 1-5, and albumin
in urine after CPB observed is in line with an impaired meg-
alin-mediated endocytosis. Thus, an impaired capacity of
megalin for endocytosis seems to be an important and rele-
vant mechanism of proteinuria after CPB.
Second, ZAG, a glucocorticoid inducible plasma protein
also known as ‘‘lipid-mobilizing factor,’’ was up-regulated
after CPB and down-regulated in patients with AKIithout acute kidney injury: Up-regulated (þ) and down-regulated (-)
eoretic MASCOT No. of matching Sequence No. of matching
r/pIy scorez peptides coverage (%) MS/MS
.5/5.7 104 17 39.4 1
.1/5.7 148 7 32.4 2
.1/5.7 174 15 55.6 3
.0/5.8 88 4 15.3 2
pot number according to Figure 2, H. yTheoretic molecular mass and isoelectric point
ool.html). zMASCOT scores>61 were significant (P< .05) identifications.
rdiovascular Surgery c Volume 139, Number 3 697
FIGURE 3. A, Representative Western blot of urinary ZAG in a patient
with and without AKI. B, Correlation between Western blot and DIGE
data of urinary ZAG in 6 patients with (C) and 6 patients without (B)
AKI. Spearman coefficient is r ¼ 0.81, P ¼ .01. C, Urinary ZAG in 23 pa-
tients with (C) and 45 patients without (B) AKI given on a logarithmic
scale. For differences between patients with and without AKI, see Results
section. D, Correlation between CPB-induced changes in eGFR and urinary
ZAG. Spearman coefficient between changes in eGFR and ZAG is r¼ 0.31,
P<.01.AKI,Acute kidney injury;DIGE, difference fluorescence gel electro-
phoresis; GFR, glomerular filtration rate; ZAG, zinc-alpha-2-glycoprotein.
Perioperative Management Aregger et al
698 The Journal of Thoracic and Cardiovascular Surg
P
Mcompared with patients without AKI. In diseases with in-
creased epithelial cell proliferation such as prostatic cancer19
and polycystic kidney disease, ZAG was found to be down-
regulated. ZAG has recently been shown to inhibit cell pro-
liferation in various cells, including renal tubular cells.20
Furthermore, in an ischemia-reperfusion model of AKI in
mice, ZAG knockdown resulted in improved tubular cell
proliferation after injury.20 Thus, it is conceivable that the
differential expression of ZAG in patients with and without
AKI is linked by an unknown mechanism with the AKI-as-
sociated tubular injury. The renal handling of ZAG is ob-
scure. For instance, it seems to be unknown whether ZAG
binds to cell surface receptors of renal cells and is taken
up into the cells. Furthermore, whether urinary ZAG derives
from glomerular plasma filtration or from tubular cells has
not been elucidated. In addition, the analysis of ZAG is com-
plicated by the fact that ZAG is induced by cortisol, a hor-
mone increased after CPB.21 The renal handling and renal
tissue availability of glucocorticoids are strongly modulated
in animals and humans with renal failure. Thus, the interplay
between ZAG and AKI deserves future investigations.
Third, cardiac surgery with the aid of CPB induces a sys-
temic inflammatory response syndrome (SIRS).22 Contact
interactions of blood components with the artificial surface
of the bypass circuit, ischemia-reperfusion injury, operative
trauma, endotoxemia, blood loss, and transfusions are all
possible causes of SIRS. The changes of albumin, leucine-
rich alpha-2-glycoprotein, mannan-binding lectin serine
protease 2, and HSPG observed in the present study might
be explained at least in part by SIRS.
For some proteins, such as gelsolin and carbonic anhy-
drase-1, we have no tentative explanation for the differential
appearance in urine after CPB. Of interest, a decreased ex-
cretion of uromodulin has been described in various renal
diseases, including acute tubular necrosis, lupus nephritis,
and CPB-associated tubulopathy. Distal tubular dysfunction
is a possible mechanism accounting for altered uromodulin
handling.
This is the first study to analyze the urinary proteome of
patients undergoing CPB with DIGE. Other methods have
been applied for the urinary protein analysis in these pa-
tients. Nguyen and colleagues23 found 4 unidentified up-reg-
ulated proteins after CPB in patients with and without AKI
by surface-enhanced laser desorption/ionization time-of-
flight mass spectrometry (SELDI-TOF-MS). Vanhoutte
and colleagues2 compared postoperative urine samples of
20 unselected patients undergoing CPB with healthy con-
trols by 2D gel electrophoresis and SELDI-TOF-MS. As
in our work, RBP, gelsolin, ZAG, carbonic anhydrase,
HSPG, and AMBP were up-regulated after CPB. In addi-
tion, Vanhouette and colleagues identified other differen-
tially regulated proteins not seen by us and vice versa,
a variance best explained by (1) the different study design in-
cluding the same well-defined subjects pre- andery c March 2010
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Mpostoperatively in the present study versus a cross-sectional
analysis; (2) sample preparations; and (3) visualization tech-
niques, that is, comparison of different gels in the study of
Vanhouette and colleagues versus CyDye, an approach al-
lowing different samples to be run on the same gel in the
present study.9 Ho and colleagues6 recently analyzed hydro-
phobic proteins by SELDI-TOF-MS and found ß2-micro-
globulin and hepcidin up-regulated after CPB. Hepcidin
and another non-identified protein of a molecular mass of
2.43 kD were up-regulated in patients without AKI.
The identification of urinary markers predicting renal in-
jury early after an insult to the kidney has occurred is a tre-
mendous undertaking. In a first step, we prospectively
analyzed urine from a well-defined small number of patients
before and after CPB by DIGE. By this approach, 3 differen-
tially regulated proteins were identified in patients with AKI:
up-regulation of a modified albumin and down-regulation of
ZAG and a fragment of AMBP. ZAG levels determined by
DIGE in the urine from the 12 patients were first confirmed
by Western blot and then validated by ELISA in a second
cross-sectional study of 68 patients after CPB. ZAG was sig-
nificantly lower in AKI urine, and its excretion correlated
with the change in eGFR. Down-regulation of ZAG was
even more pronounced in severe AKI, such as injury and
failure. Thus, ZAG might serve as a predictive marker in
AKI after CPB. In recent years, several urinary biomarkers
have been proposed for early detection of AKI after cardiac
surgery, including neutrophil gelatinase-associated lipocalin
(NGAL). An outstanding performance of NGAL in the early
diagnosis of AKI has been reported in the homogenous pop-
ulation of pediatric patients undergoing cardiac surgery. In
this population, an AUC value was reported to be as high
as 0.98. The corresponding values from non-pediatric pa-
tients were not that promising and ranged between 0.5 and
0.96.24,25 It seems that the predictive value of NGAL de-
pends on the time point of the assessments because the
best discrimination between patients with and without AKI
was 2 to 6 hours after cardiac surgery. Emerging experimen-
tal and clinical evidence indicates that NGAL protein ex-
pression is up-regulated in the distal nephron and that
urinary secretion results in higher amounts of NGAL after
tubular damage. The AUC of ZAG is is in the reported range
of NGAL.
Study Limitations
First, the urinary proteome consists of a large number of
different proteins, and 2 subsequent protein separation tech-
niques are not feasible to separate all of them in a satisfactory
manner. Furthermore, proteins within a given proteome are
structurally diverse and present various physicochemical
characteristics. Some of these proteins are alkaline or hydro-
phobic, are of poor solubility, or have different staining char-
acteristics. Therefore, the present study in the urinary
proteome of patients undergoing CPB revealed differentialThe Journal of Thoracic and Caregulation of interesting proteins but could not detect all of
them. Second, some of the differentially regulated spots
could not be identified because of very low abundance. Be-
cause the sensitivity of CyDyes is higher than that of Coo-
massie dye, which is used for gel staining and spot
picking, some spots cannot be identified even on a prepara-
tive gel. Third, antifibrinolytic therapy was different be-
tween groups A and B because of a change in local
practice during the study period. Patients with and without
AKI were given the same antifibrinolytic therapy within
the groups. Down-regulation of ZAG was present in both
groups in patients with AKI. Therefore, we do not believe
the change in treatment biased the study results.CONCLUSIONS
The present investigation demonstrates that DIGE allows
unraveling new potentially interesting markers of CPB-asso-
ciated AKI. After identification of such potential markers
with the sensitive and specific but time-consuming and ex-
pensive DIGE technique applied in the present investigation,
the candidate proteins can be considered for clinical practice
after validation in larger cohorts by quantifying the proteins
with ELISA in a fast and inexpensive manner. Two main
groups of differentially regulated proteins were identified:
inflammation-associated or candidates of megalin-mediated
endocytosis. ZAG is a potential marker for early prediction
of AKI after CPB.
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